GB2429711A - Heart and skeletal muscle inflammation (HSMI) virus - Google Patents

Heart and skeletal muscle inflammation (HSMI) virus

Info

Publication number
GB2429711A
GB2429711A GB0625374A GB0625374A GB2429711A GB 2429711 A GB2429711 A GB 2429711A GB 0625374 A GB0625374 A GB 0625374A GB 0625374 A GB0625374 A GB 0625374A GB 2429711 A GB2429711 A GB 2429711A
Authority
GB
United Kingdom
Prior art keywords
heart
hsmi
muscle inflammation
virus
skeletal muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0625374A
Other versions
GB0625374D0 (en
GB2429711B (en
Inventor
Trygve Meum Eliassen
Inge Tom Solbakk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaq AS
Original Assignee
Pharmaq AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20042454A external-priority patent/NO20042454D0/en
Application filed by Pharmaq AS filed Critical Pharmaq AS
Publication of GB0625374D0 publication Critical patent/GB0625374D0/en
Publication of GB2429711A publication Critical patent/GB2429711A/en
Application granted granted Critical
Publication of GB2429711B publication Critical patent/GB2429711B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12061—Methods of inactivation or attenuation
    • C12N2720/12064—Methods of inactivation or attenuation by serial passage

Abstract

The present invention relates to an isolated Heart and Skeleton Muscle Inflammation Virus (HSMIV) derived from fish; a live, attenuated or inactivated HSMIV, or parts of it functional for vaccine purposes, a recombinant antigen and vaccine; as well as DNA, cell lines, vaccines, antibodies, methods and uses thereof. The invention may be utilized to prevent and diagnose Heart and Skeleton Muscle Inflammation (HSMI) in fish.
GB0625374A 2004-06-11 2005-06-10 Heart and skeletal muscle inflammation (HSMI) virus Active GB2429711B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20042454A NO20042454D0 (en) 2004-06-11 2004-06-11 Novel fish virus
US57882104P 2004-06-14 2004-06-14
PCT/NO2005/000197 WO2005121325A1 (en) 2004-06-11 2005-06-10 Heart and skeletal muscle inflammation (hsmi) virus

Publications (3)

Publication Number Publication Date
GB0625374D0 GB0625374D0 (en) 2007-01-31
GB2429711A true GB2429711A (en) 2007-03-07
GB2429711B GB2429711B (en) 2008-05-21

Family

ID=34993270

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0625374A Active GB2429711B (en) 2004-06-11 2005-06-10 Heart and skeletal muscle inflammation (HSMI) virus

Country Status (4)

Country Link
CA (1) CA2570050C (en)
GB (1) GB2429711B (en)
NO (1) NO343278B1 (en)
WO (1) WO2005121325A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8562802B1 (en) 2006-02-13 2013-10-22 Life Technologies Corporation Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems
NO346433B1 (en) * 2007-06-28 2022-08-08 Pharmaq As New fish pathogen
NO20081040L (en) * 2008-02-27 2009-08-28 Thia Medica As Reduced HSMI mortality
CA2776534A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions
EP2640832B1 (en) 2010-11-15 2017-12-20 Pharmaq AS New ethiological agent
AU2014314140B2 (en) * 2013-08-30 2020-10-22 Pharmaq As Method for propagating a virus
CA3158539A1 (en) 2019-12-16 2021-06-24 Johanna Jacoba Elisabeth Bijlsma Inactivated piscine orthoreovirus vaccine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DISEASES OF AQUATIC ORGANISMS, vol. 59, 2004, RT Kongtorp et al, "Pathology of heart and skeletal muscle inflammation (HSMI) in farmed Atlantic salmon Salmo salar", pages 217-224 *
JOURNAL OF FISH DISEASES, vol. 27, 2004, RT Kongtrop et al, "Heart and skeletal muscle inflammation in Atlantic salmon, Salmo salar L.: a new infectious disease" pages 351-358 *
TM Eliassen et al, 2004, "Isolation of Heart and Skeletal Muscle Inflammation Virus (HSMIV) from Salmon", Retrieved from the Internet: URL:http://www.pharmaq.no/Posters/HSMIV_poster.pdf> *

Also Published As

Publication number Publication date
NO20065765L (en) 2007-01-11
GB0625374D0 (en) 2007-01-31
CA2570050A1 (en) 2005-12-22
NO343278B1 (en) 2019-01-14
WO2005121325A1 (en) 2005-12-22
GB2429711B (en) 2008-05-21
CA2570050C (en) 2013-03-05

Similar Documents

Publication Publication Date Title
EP3266464A3 (en) Yeast-based therapeutic for chronic hepatitis b infection
EP1594536A4 (en) Adjuvanted influenza vaccine
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
WO2007039192A3 (en) Compositions and methods for treating tumors presenting survivin antigens
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
HK1125051A1 (en) Virus-like particles as vaccines for paramyxovirus
MXPA05009580A (en) Influenza virus vaccine.
WO2008039267A3 (en) Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
WO2010149752A3 (en) Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
WO2006115843A3 (en) Nipah virus vaccines
PL1951300T3 (en) Changing th1/th2 balance in split influenza vaccines with adjuvants
WO2010074575A3 (en) Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.
WO2009026465A3 (en) Composition and methods of making and using influenza proteins
WO2009135199A3 (en) Vaccine compositions and methods
WO2008005880A3 (en) Antibodies for norovirus
EA201390676A1 (en) VACCINES CONTAINING NON-SPECIFIC NUCLEOSIDE HYDROLASE POLYPEPTIDES AND STEROL 24-C-Methyltransferase (SMT), for the treatment and diagnosis of leishmaniasis
WO2007119011A9 (en) N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family
WO2007078879A3 (en) Lipopeptide compositions and methods of use thereof
MX2009007572A (en) Fusion protein.
EP3932418A3 (en) Peptides for use in promoting transport of glucose
WO2006085979A3 (en) Soluble forms of hendra and nipah virus g glycoprotein
TW200634156A (en) Neutralizing epitope-based growth enhancing vaccine
WO2005108560A3 (en) Synthesis and purification of west nile virus virus-like particles

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20130815 AND 20130821